RexLeveraged EquityNVII · Cboe BZX
REX NVDA Growth & Income ETF (NVII)
- Price
- $23.93
- —11 Sept 2026
- Assets
- $116.1M
- Total net assets
- Expense ratio
- 1.49%
- Category 0.00%
- Yield
- 55.22%
- Trailing distributions
- 3Y CAGR
- —
- Category 25.3%
- 5Y CAGR
- —
- Category 6.1%
Loading NAV history…
REX NVDA Growth & Income ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
Holdings
Allocation as last published by the fund.
Credit quality
Share of the bonds by rating.
- US government97.1%
Asset mix
- Cash99.5%
- Stocks1.8%
ETF details
- Issuer
- Rex
- Category
- Equity · Leveraged Equity
- Ticker
- NVII
- Exchange
- Cboe BZX
- Inception
- 27 May 2025 (1.3 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 1.49% (category 0.00%)
- Holdings turnover
- 0%
- Distribution yield
- 55.22%
- Beta, 3 years
- 0.00
- Total net assets
- $116.1M
Prices and returns as of 11 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other leveraged equity ETFs
Other ETFs in the Leveraged Equity category.
- CRWG · Leverage Shares 2X Long CRWV Daily ETFThemes ETF Trust · $114.5M · ER 0.77%
- GLWG · Leverage Shares 2X Long GLW Daily ETFThemes ETF Trust · $110.6M · ER 0.75%
- MRVU · Direxion Daily MRVL Bull 2X ETFDirexion Funds · $107.5M · ER 0.97%
- ROBN · T-Rex 2X Long HOOD Daily Target ETFRex · $104M · ER 1.05%
- BIB · ProShares Ultra Nasdaq BiotechnologyProShares · $101.4M · ER 0.95%5Y 1.3%
- BRZU · Direxion Daily MSCI Brazil Bull 2X ETFDirexion Funds · $100.9M · ER 1.32%5Y 7.4%